Company Registration No. 07126043 (England and Wales)
LIFESCIENCES HEALTHCARE LIMITED
DIRECTOR'S REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016
LIFESCIENCES HEALTHCARE LIMITED
COMPANY INFORMATION
Director
Dr G Lushai
Company number
07126043
Registered office
Kings Parade
Lower Coombe Street
Croydon
CR0 1AA
Accountants
Bryden Johnson
Kings Parade
Lower Coombe Street
Croydon
CR0 1AA
Business address
The Engine Shed
Station Approach
Bristol
BS1 6QH
LIFESCIENCES HEALTHCARE LIMITED
CONTENTS
Page
Director's report
1
Accountants' report
2
Profit and loss account
3
Balance sheet
4
Notes to the financial statements
5 - 8
LIFESCIENCES HEALTHCARE LIMITED
DIRECTOR'S REPORT
FOR THE YEAR ENDED 31 MARCH 2016
- 1 -
The director presents his report and financial statements for the year ended 31 March 2016.
Director
The following director has held office since 1 April 2015:
Dr G Lushai
This report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.
On behalf of the board
Dr G Lushai
Director
30 November 2016
LIFESCIENCES HEALTHCARE LIMITED
CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF LIFESCIENCES HEALTHCARE LIMITED FOR THE YEAR ENDED 31 MARCH 2016
- 2 -
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Lifesciences Healthcare Limited for the year ended 31 March 2016 set out on pages 3 to 8 from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales, we are subject to its ethical and other professional requirements which are detailed at icaew.com/regulations.
This report is made solely to the Board of Directors of Lifesciences Healthcare Limited, as a body, in accordance with the terms of our engagement letter dated 14 August 2013. Our work has been undertaken solely to prepare for your approval the financial statements of Lifesciences Healthcare Limited and state those matters that we have agreed to state to the Board of Directors of Lifesciences Healthcare Limited, as a body, in this report in accordance with AAF 2/10 as detailed at icaew.com/compilation. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Lifesciences Healthcare Limited and its Board of Directors as a body, for our work or for this report.
It is your duty to ensure that Lifesciences Healthcare Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Lifesciences Healthcare Limited. You consider that Lifesciences Healthcare Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Lifesciences Healthcare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Bryden Johnson
13 December 2016
Chartered Accountants
Kings Parade
Lower Coombe Street
Croydon
CR0 1AA
LIFESCIENCES HEALTHCARE LIMITED
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2016
- 3 -
2016
2015
Notes
£
£
Turnover
37,517
31,486
Cost of sales
(2,519)
(3,206)
Gross profit
34,998
28,280
Administrative expenses
(30,123)
(22,594)
Profit on ordinary activities before taxation
2
4,875
5,686
Tax on profit on ordinary activities
3
-
-
Profit for the year
9
4,875
5,686
LIFESCIENCES HEALTHCARE LIMITED
BALANCE SHEET
AS AT
31 MARCH 2016
31 March 2016
- 4 -
2016
2015
Notes
£
£
£
£
Current assets
Debtors
5
13,213
10,500
Cash at bank and in hand
570
399
13,783
10,899
Creditors: amounts falling due within one year
6
(6,916)
(10,907)
Total assets less current liabilities
6,867
(8)
Creditors: amounts falling due after more than one year
7
(22,789)
(20,789)
(15,922)
(20,797)
Capital and reserves
Called up share capital
8
100
100
Profit and loss account
9
(16,022)
(20,897)
Shareholders' funds
10
(15,922)
(20,797)
For the financial year ended 31 March 2016 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
-
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and the Financial Reporting Standard for Smaller Entities (effective January 2015).
Approved by the Board for issue on 30 November 2016
Dr G Lushai
Director
Company Registration No. 07126043
LIFESCIENCES HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016
- 5 -
1
Accounting policies
1.1
Accounting convention
The financial statements are prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective January 2015).
The company meets its day to day working capital requirements through the continued support of its director.
On this basis, the director considers it appropriate to prepare the financial statements on the going concern basis however inherently there can be no certainty in relation to these matters.
1.2
Turnover
Turnover represents amounts receivable for goods and services net of VAT and trade discounts.
1.3
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:
Computer equipment
25% Straight Line
Fixtures, fittings & equipment
20% Straight Line
2
Operating profit
2016
2015
£
£
Operating profit is stated after charging:
Director's remuneration
12,000
12,000
3
Taxation
The company has estimated losses of £ 5,700 (2015 - £ 11,225) available for carry forward against future trading profits.
On the basis of these financial statements no provision has been made for corporation tax.
LIFESCIENCES HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2016
- 6 -
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2015 & at 31 March 2016
401
Depreciation
At 1 April 2015 & at 31 March 2016
401
Net book value
At 31 March 2016
-
At 31 March 2015
-
5
Debtors
2016
2015
£
£
Trade debtors
2,806
10,500
Other debtors
10,407
-
13,213
10,500
6
Creditors: amounts falling due within one year
2016
2015
£
£
Trade creditors
395
114
Taxation and social security
5,221
2,071
Other creditors
1,300
8,722
6,916
10,907
7
Creditors: amounts falling due after more than one year
2016
2015
£
£
Other creditors
22,789
20,789
Analysis of loans
Wholly repayable within five years
22,789
20,789
The loan
notes listed above are not secured.
LIFESCIENCES HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2016
- 7 -
8
Share capital
2016
2015
£
£
Allotted, called up and fully paid
100 Ordinary of £1 each
100
100
9
Statement of movements on profit and loss account
Profit
and loss
account
£
Balance at 1 April 2015
(20,897)
Profit for the year
4,875
Balance at 31 March 2016
(16,022)
10
Reconciliation of movements in Shareholders' funds
2016
2015
£
£
Profit for the financial year
4,875
5,686
Opening Shareholders' funds
(20,797)
(26,483)
Closing Shareholders' funds
(15,922)
(20,797)
11
Control
There is no ultimate controlling party.
12
Related party relationships and transactions
Loans to directors
The following director had interest free loans during the year. The movement on these loans are as follows:
Description
% Rate
Opening Balance
Amounts Advanced
Interest Charged
Amounts Repaid
Closing Balance
£
£
£
£
£
Interest free
-
-
8,326
-
-
8,326
-
8,326
-
-
8,326
LIFESCIENCES HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2016
12
Related party relationships and transactions
(Continued)
- 8 -
During the year the company purchased services for £700 (2015 - £Nil) from Medilink South West Limited, Dr G Lushai is a director of Medilink South West Limited.
During the year the company made sales to Medilink South West Limited in the amount of £Nil (2015 - £1,100).
2016-03-31
2015-04-01
false
true
true
true
true
true
tmp448F.html
2016-12-13
07126043
2015-04-01
2016-03-31
07126043
uk-bus:Director1
2015-04-01
2016-03-31
07126043
uk-bus:RegisteredOffice
2015-04-01
2016-03-31
07126043
uk-bus:EntityAccountantsOrAuditors
2015-04-01
2016-03-31
07126043
2016-03-31
07126043
uk-bus:EntityAccountantsOrAuditors
2016-03-31
07126043
2014-04-01
2015-03-31
07126043
2015-03-31
07126043
2015-03-31
07126043
2014-03-31
07126043
uk-gaap:ComputerEquipment
2015-04-01
2016-03-31
07126043
uk-gaap:FixturesFittingsToolsEquipment
2015-04-01
2016-03-31
07126043
uk-bus:AllEntityOfficers
2015-04-01
2016-03-31
07126043
uk-bus:AllEntityOfficers
2014-04-01
2015-03-31
07126043
uk-bus:OrdinaryShareClass1
2015-04-01
2016-03-31
07126043
uk-bus:OrdinaryShareClass1
2016-03-31
07126043
uk-bus:OrdinaryShareClass1
2015-03-31
xbrli:pure
xbrli:shares
iso4217:GBP